Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for biosimilars
Takeda v Roche: "Is it plausible? Is it true?" Takeda v Roche: "Is it plausible? Is it true?" Reviewed by Dr Rose Hughes on Thursday, August 01, 2019 Rating: 5
Roche shields itself from a UK Arrow: Pfizer v Roche Roche shields itself from a UK Arrow: Pfizer v Roche Reviewed by Dr Rose Hughes on Thursday, June 27, 2019 Rating: 5
Fordham 27 (Report 9): Biologics and Biosimilars Fordham 27 (Report 9): Biologics and Biosimilars Reviewed by Annsley Merelle Ward on Sunday, April 28, 2019 Rating: 5
Shall we dance? Regulatory approval, trade secrets and the transatlantic biosimilars patent wars Shall we dance? Regulatory approval, trade secrets and the transatlantic biosimilars patent wars Reviewed by Annsley Merelle Ward on Sunday, March 12, 2017 Rating: 5
Biosimilars and generics as "rip-offs": when the facts may not matter Biosimilars and generics as "rip-offs": when the facts may not matter Reviewed by Neil Wilkof on Friday, March 10, 2017 Rating: 5
Amgen, Pfizer, Alphabet and Uber face up to trade secrets in biosimilars, self driving cars and product launch plans Amgen, Pfizer, Alphabet and Uber face up to trade secrets in biosimilars, self driving cars and product launch plans Reviewed by Annsley Merelle Ward on Thursday, March 09, 2017 Rating: 5
Will the Arrow hit the Humira target? Find out tomorrow! Will the Arrow hit the Humira target? Find out tomorrow! Reviewed by Annsley Merelle Ward on Thursday, March 02, 2017 Rating: 5
AIPPI Congress Report 3: Biosimilars – similar but different? AIPPI Congress Report 3: Biosimilars – similar but different? Reviewed by Annsley Merelle Ward on Friday, September 23, 2016 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.